The two-day Pharma Innovation & Policy Summit in Amsterdam (May 12–13, 2026) will bring together leading figures from academia, industry, regulators, and public health agencies. The agenda includes sessions on drug discovery, personalized medicine, regulatory harmonization, clinical trials, biomanufacturing, supply chain resilience, and health economics. Renowned keynote speakers will address challenges around antimicrobial resistance, gene and cell therapies, and digital health integration. Breakout tracks will allow deep dives into emerging modalities, market access strategies, and public–private partnerships for global access. Attendees can present posters, engage in interactive roundtables, or participate in matchmaking sessions and networking dinners. The venue—located in central Amsterdam—features modern conference halls, exhibition space for service providers, and easy accessibility. The summit promises to facilitate cross-disciplinary collaboration, spark translational research opportunities, and influence policy discourse in Europe and beyond.